# Docetaxel and Irinotecan in Gastric Cancer

> **NCT04770623** · PHASE2 · COMPLETED · sponsor: **Menoufia University** · enrollment: 32 (actual)

## Conditions studied

- Stomach Cancer
- Gastric Cancer
- Chemotherapy Effect

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT04770623
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-05
- **Primary completion:** 2023-01-09
- **Final completion:** 2023-01-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04770623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04770623, "Docetaxel and Irinotecan in Gastric Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04770623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*